Biological Intellectual Property Protection Act of 2025 restricts export of synthetic DNA or RNA sequences to foreign entities of concern.
The Biological Intellectual Property Protection Act of 2025 aims to safeguard U.S. intellectual property and sensitive information related to synthetic biology by imposing a license requirement for the export of synthetic DNA or RNA sequences to foreign entities of concern. This act addresses the threat posed by foreign adversaries, particularly the People's Republic of China, which is leveraging its military-civil fusion strategy to access and exploit U.S. data and intellectual property for military and intelligence purposes.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.